HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis M Branco Selected Research

Lassa Fever (Fever, Lassa)

11/2021Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
11/2020Elevated L-threonine is a biomarker for Lassa fever and Ebola.
1/2020Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
1/2020Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone.
4/2019Data set on Lassa fever in post-conflict Sierra Leone.
1/2019Antibody therapy for Lassa fever.
12/2018Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
10/2017Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.
10/2016Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
1/2016Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luis M Branco Research Topics

Disease

17Lassa Fever (Fever, Lassa)
11/2021 - 06/2008
12Infections
01/2022 - 09/2009
6Fever (Fevers)
10/2016 - 10/2010
3Ebola Hemorrhagic Fever
11/2020 - 10/2016
2COVID-19
11/2021 - 01/2021
2Viremia
10/2011 - 11/2010
1Severe Acute Respiratory Syndrome
11/2021
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021
1Vesicular Stomatitis
10/2020
1Epidemic Louse-Borne Typhus (Typhus)
02/2015
1Dizziness (Lightheadedness)
11/2014
1Diarrhea
11/2014
1Inflammation (Inflammations)
10/2011
1Fetal Death
08/2011
1Virus Diseases (Viral Diseases)
11/2010

Drug/Important Bio-Agent (IBA)

6Glycoproteins (Glycoprotein)IBA
01/2022 - 12/2008
6AntibodiesIBA
01/2022 - 12/2008
6Monoclonal AntibodiesIBA
01/2022 - 01/2016
6VaccinesIBA
01/2022 - 10/2010
6AntigensIBA
10/2020 - 10/2011
5Proteins (Proteins, Gene)FDA Link
11/2021 - 12/2008
4Immunoglobulin G (IgG)IBA
01/2020 - 10/2011
4Immunoglobulin M (IgM)IBA
01/2020 - 10/2011
4Ribavirin (Virazole)FDA LinkGeneric
04/2019 - 10/2010
2EpitopesIBA
11/2021 - 10/2010
2ImmunosorbentsIBA
11/2021 - 02/2015
2EnzymesIBA
11/2021 - 02/2015
2Indicators and Reagents (Reagents)IBA
09/2009 - 06/2008
1Lysosomal Membrane ProteinsIBA
01/2022
1casirivimab and imdevimab drug combinationIBA
01/2021
1Threonine (L-Threonine)FDA Link
11/2020
1Amino AcidsFDA Link
11/2020
1Biomarkers (Surrogate Marker)IBA
11/2020
1Platelet Activating FactorIBA
11/2020
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2020
1NucleoproteinsIBA
01/2020
1Recombinant ProteinsIBA
01/2020
1ZincIBA
01/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2014
1Urea (Carbamide)FDA LinkGeneric
11/2014
1CreatinineIBA
11/2014
1NitrogenIBA
11/2014
1Nucleic AcidsIBA
10/2011
1Antimalarials (Antimalarial Agents)IBA
06/2011
1Anti-Bacterial Agents (Antibiotics)IBA
06/2011
1CytokinesIBA
06/2011
1Protein Isoforms (Isoforms)IBA
11/2010
1Viral AntigensIBA
11/2010
1NucleotidesIBA
10/2010
1Pharmaceutical PreparationsIBA
10/2010
1Antiviral Agents (Antivirals)IBA
09/2009

Therapy/Procedure

4Therapeutics
01/2022 - 11/2010
1Drug Therapy (Chemotherapy)
01/2021
1Oral Administration
10/2010
1Intravenous Administration
10/2010